News Releases

  • 20 Feb 2015
    Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced today that James C. Mullen, CEO, will present an update on the company’s financial standing at the J.P. Morgan Global High Yield and Leveraged Finance Conference at the Loews Miami Beach Hotel in Miami, on Monday, Feb. 23 at 4 p.m.About PatheonPatheon, a business unit of DPx Holdings B.V., delivers a combination of unrivaled quality, reliability andmore...